Barclays
OSCR icon

Barclays’s Oscar Health OSCR Stock Holding History

Barclays’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.7M Buy
442,681
+112,896
+34% +$3.47M ﹤0.01% 1470
2026
Q2 		$9.41M Sell
329,785
-97,721
-23% -$2.1M ﹤0.01% 1510
2026
Q1 		$4.9M Sell
427,506
-239,238
-36% -$3.37M ﹤0.01% 1834
2025
Q4 		$9.6M Buy
666,744
+269,304
+68% +$4.66M ﹤0.01% 1712
2025
Q3 		$7.52M Buy
397,440
+28,282
+8% +$466K ﹤0.01% 1889
2025
Q2 		$7.91M Buy
369,158
+96,165
+35% +$1.43M ﹤0.01% 1736
2025
Q1 		$3.58M Sell
272,993
-88,069
-24% -$1.31M ﹤0.01% 2180
2024
Q4 		$4.85M Buy
361,062
+35,244
+11% +$567K ﹤0.01% 2201
2024
Q3 		$6.91M Buy
325,818
+223,189
+217% +$4.02M ﹤0.01% 1777
2024
Q2 		$1.62M Sell
102,629
-51,277
-33% -$942K ﹤0.01% 2286
2024
Q1 		$2.29M Sell
153,906
-183,730
-54% -$2.52M ﹤0.01% 2458
2023
Q4 		$3.09M Buy
337,636
+234,358
+227% +$1.62M ﹤0.01% 2538
2023
Q3 		$575K Buy
103,278
+51,268
+99% +$359K ﹤0.01% 2704
2023
Q2 		$419K Sell
52,010
-9,288
-15% -$68.5K ﹤0.01% 2865
2023
Q1 		$401K Sell
61,298
-840
-1% -$3.43K ﹤0.01% 3418
2022
Q4 		$153K Buy
62,138
+57,129
+1,141% +$179K ﹤0.01% 3992
2022
Q3 		$25K Sell
5,009
-28,323
-85% -$165K ﹤0.01% 3994
2022
Q2 		$141K Buy
33,332
+24,536
+279% +$156K ﹤0.01% 3611
2022
Q1 		$88K Buy
+8,796
New +$65.4K ﹤0.01% 3845

Other funds holding OSCR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Barclays's OSCR Position: Q3 2026 in Review

Barclays increased its Oscar Health (OSCR) stake by 34% in Q3 2026, buying an estimated $3.47M and bringing the position to 442,681 shares worth $13.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Barclays first reported a position in OSCR in Q1 2022 and has held it in 19 quarters since. 320 funds tracked by Wall St. Rank hold OSCR as of Q3 2026.

  • Barclays held 442,681 shares of Oscar Health worth $13.7M as of Q3 2026.
  • Barclays bought 112,896 Oscar Health shares in Q3 2026, an estimated $3.47M.
  • Oscar Health made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1470 holding.
  • Barclays first reported a position in Oscar Health in Q1 2022 and has held it in 19 quarters since.
  • 320 funds tracked by Wall St. Rank held Oscar Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.